Cite
HARVARD Citation
Gentile, M. et al. (2016). Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials. European journal of cancer. pp. 154-165. [Online].